$107.51
1.33[1.25%]
At close: Apr 26
$107.51
0[0.00%]
After Hours: 7:59PM EDT
Moderna: Insider buying and selling updated today.
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
---|---|---|---|---|---|---|---|---|---|---|
Apr 26, 2024 | Noubar B. Afeyan Ph.D. By: Noubar B. Afeyan, Ph.D. | -15K | $108.32 | -$1.62M | SELL | -0.73% | 2.045855M | Apr 24 | View | |
Apr 19, 2024 | Noubar B. Afeyan Ph.D. By: Noubar B. Afeyan, Ph.D. | -15K | $103.38 | -$1.55M | SELL | -0.72% | 2.060855M | Apr 17 | View | |
Apr 16, 2024 | Stephen Hoge | PRESIDENT | -15K | $105.02 | -$1.58M | SELL | -0.91% | 1.638174M | Apr 15 | View |
Apr 12, 2024 | Noubar B. Afeyan Ph.D. By: Noubar B. Afeyan, Ph.D. | -15K | $107.12 | -$1.61M | SELL | -0.72% | 2.075855M | Apr 10 | View | |
Apr 09, 2024 | James Mock | CHIEF FINANCIAL OFFICER | 748 | $101.93 | -$71.86K | SELL-OPTIONS | 17.40% | 5.048K | Apr 05 - Apr 08 | View |
Apr 05, 2024 | Noubar B. Afeyan Ph.D. By: Noubar B. Afeyan, Ph.D. | -15K | $101.68 | -$1.53M | SELL | -0.71% | 2.090855M | Apr 03 | View | |
Mar 29, 2024 | Noubar B. Afeyan Ph.D. By: Noubar B. Afeyan, Ph.D. | -15K | $109.06 | -$1.64M | SELL | -0.71% | 2.105855M | Mar 27 | View | |
Mar 22, 2024 | Noubar B. Afeyan Ph.D. By: Noubar B. Afeyan, Ph.D. | -15K | $102.39 | -$1.54M | SELL | -0.70% | 2.120855M | Mar 20 | View | |
Mar 19, 2024 | Stephen Hoge | PRESIDENT | -15K | $103.17 | -$1.55M | SELL | -0.90% | 1.653174M | Mar 15 | View |
Mar 15, 2024 | Noubar B. Afeyan Ph.D. By: Noubar B. Afeyan, Ph.D. | -15K | $108.54 | -$1.63M | SELL | -0.70% | 2.135855M | Mar 13 | View | |
Mar 11, 2024 | Thyme Shannon Klinger | CHIEF LEGAL OFFICER | 594 | $99.05 | -$53.88K | SELL-OPTIONS | 6.85% | 9.267K | Mar 07 - Mar 08 | View |
Mar 05, 2024 | Thyme Shannon Klinger | CHIEF LEGAL OFFICER | 116 | $94.34 | -$11.04K | SELL-OPTIONS | 1.36% | 8.673K | Mar 01 - Mar 04 | View |
Mar 05, 2024 | Stephen Hoge | PRESIDENT | 343 | $94.34 | -$29.15K | SELL-OPTIONS | 0.02% | 1.668174M | Mar 01 - Mar 04 | View |
Mar 01, 2024 | James Mock | CHIEF FINANCIAL OFFICER | 668 | $94.57 | -$61.19K | SELL-OPTIONS | 18.39% | 4.3K | Feb 28 - Feb 29 | View |
Mar 01, 2024 | Thyme Shannon Klinger | CHIEF LEGAL OFFICER | 645 | $94.57 | -$63.36K | SELL-OPTIONS | 8.15% | 8.557K | Feb 28 - Feb 29 | View |
Mar 01, 2024 | Stephen Hoge | PRESIDENT | 2.465K | $94.57 | -$225.84K | SELL-OPTIONS | 0.15% | 1.667831M | Feb 28 - Feb 29 | View |
Feb 23, 2024 | Stephen Hoge | PRESIDENT | -15K | $100.00 | -$1.50M | SELL | -0.89% | 1.665366M | Feb 22 | View |
Feb 16, 2024 | Stephen Hoge | PRESIDENT | 12.152K | $88.88 | -$936.98K | GRANT | 0.73% | 1.680366M | Feb 14 - Feb 16 | View |
Feb 16, 2024 | Stephane Bancel | CHIEF EXECUTIVE OFFICER | 30.385K | $88.88 | -$2.34M | GRANT | 0.25% | 12.025104M | Feb 14 - Feb 16 | View |
Browse insider trades on all stocks.